Bachem Holding AG
BANB
Rang in Aktien
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aktienkurs
$100.60
Marktkapitalisierung
$7.54B
Veränderung (1 Tag)
-1.49%
Veränderung (1 Jahr)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)
Kategorie
Healthcare
Operative Marge für Bachem Holding AG (BANB)
Operative Marge zum October 2026 TTM: 19.41%
Laut den neuesten Finanzberichten und dem Aktienkurs von Bachem Holding AG beträgt die aktuelle operative Marge (TTM) 19.41%. Am Ende des Jahres 2024 lag die operative Marge bei 21.98%.
Historie der operativen Marge von Bachem Holding AG von 2002 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 19.41% | -10.22% |
| 2025 | 21.62% | -1.64% |
| 2024 | 21.98% | -1.92% |
| 2023 | 22.41% | -5.64% |
| 2022 | 23.75% | -6.64% |
| 2021 | 25.44% | 6.76% |
| 2020 | 23.83% | 21.64% |
| 2019 | 19.59% | 0.98% |
| 2018 | 19.40% | 1.15% |
| 2017 | 19.18% | 0.68% |
| 2016 | 19.05% | 3.25% |
| 2015 | 18.45% | 0.22% |
| 2014 | 18.41% | 6.72% |
| 2013 | 17.25% | 23.04% |
| 2012 | 14.02% | 37.59% |
| 2011 | 10.19% | -0.59% |
| 2010 | 10.25% | -63.37% |
| 2009 | 27.98% | -21.69% |
| 2008 | 35.73% | -2.19% |
| 2007 | 36.53% | 12.54% |
| 2006 | 32.46% | 6.11% |
| 2005 | 30.59% | 7.03% |
| 2004 | 28.58% | -14.64% |
| 2003 | 33.48% | 3.98% |
| 2002 | 32.20% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 38.59% | -98.01% |
US
|
|
| -149.01% | -107.68% |
US
|
|
| 25.57% | -98.68% |
AU
|
|
| 28.81% | -98.52% |
NL
|
|
| 0.00% | - |
CH
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.